Explore

Trendline Trendline
Latigo Biotherapeutics Appoints Sara M. Bonstein to Board and Audit Committee

Latigo Biotherapeutics Appoints Sara M. Bonstein to Board and Audit Committee

Latigo Biotherapeutics Appoints Sara M. Bonstein to Board and Audit Committee
Trendline Trendline
enGene Therapeutics Inc. Announces Name Change Reflecting Transition to Commercial Organization

enGene Therapeutics Inc. Announces Name Change Reflecting Transition to Commercial Organization

enGene Therapeutics Inc. Announces Name Change Reflecting Transition to Commercial Organization
Trendline Trendline
Laurentian Bank Elects New Board of Directors Amid Shareholder Meeting

Laurentian Bank Elects New Board of Directors Amid Shareholder Meeting

Laurentian Bank Elects New Board of Directors Amid Shareholder Meeting
Trendline Trendline
NanoViricides Files for Rare Pediatric Disease Drug Designation for Measles Treatment NV-387

NanoViricides Files for Rare Pediatric Disease Drug Designation for Measles Treatment NV-387

NanoViricides Files for Rare Pediatric Disease Drug Designation for Measles Treatment NV-387
Trendline Trendline
Biocon Launches Denosumab Biosimilars in U.S. to Address Osteoporosis and Cancer-Related Bone Issues

Biocon Launches Denosumab Biosimilars in U.S. to Address Osteoporosis and Cancer-Related Bone Issues

Biocon Launches Denosumab Biosimilars in U.S. to Address Osteoporosis and Cancer-Related Bone Issues
Trendline Trendline
Activist Investor Criticizes Novavax Over Vaccine Sales and Management

Activist Investor Criticizes Novavax Over Vaccine Sales and Management

Activist Investor Criticizes Novavax Over Vaccine Sales and Management
Trendline Trendline
Novavax Shareholder Challenges CEO Pay Amidst Financial Struggles

Novavax Shareholder Challenges CEO Pay Amidst Financial Struggles

Novavax Shareholder Challenges CEO Pay Amidst Financial Struggles
Trendline Trendline
David Woodcock Appointed as SEC's New Enforcement Director Amid Staff Reductions

David Woodcock Appointed as SEC's New Enforcement Director Amid Staff Reductions

David Woodcock Appointed as SEC's New Enforcement Director Amid Staff Reductions
Trendline Trendline
Jeito Capital Closes Record $1.2 Billion Biopharma Fund to Boost European Innovation

Jeito Capital Closes Record $1.2 Billion Biopharma Fund to Boost European Innovation

Jeito Capital Closes Record $1.2 Billion Biopharma Fund to Boost European Innovation
Trendline Trendline
Murphy USA Appoints Donald R. Smith Jr. as Permanent CFO Following Leadership Changes

Murphy USA Appoints Donald R. Smith Jr. as Permanent CFO Following Leadership Changes

Murphy USA Appoints Donald R. Smith Jr. as Permanent CFO Following Leadership Changes
Trendline Trendline
Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding into Metabolic Disorders

Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding into Metabolic Disorders

Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding into Metabolic Disorders
Trendline Trendline
Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline